Heart disease is a leading cause of mortality worldwide, resulting in nearly 18 million deaths annually. It is a 1-trillion-euro economic burden on healthcare systems, which it is expected to increase in the coming years.
80% of fatal heart diseases can be prevented through early detection. However, current cardiac evaluation process is slow and delivers subjective results that lack systematic recording and follow-up. Patients must undergo a multi-step time-consuming evaluation in various locations. As a result, abnormalities that cause heart disease often go undetected until it is too late.
Solution (product or service)
Sonai is a 4-point measurement technology for cardiac evaluation. Our patent-pending solution integrates multiple diagnostics tools into a single sensor that detects abnormalities in the heart without the need for multi-step tests.
Sonai performs simultaneous measurement of the heart from multiple angles, resulting in the collection of required data for accurate AI-driven analysis and follow-up.
Business model
The business model is a combination of hardware sales and recurring revenue from service. Despite of advanced technology, the manufacturing costs are low enough to offer competitive pricing against alternative solutions as well as to maintain decent profitability.
We plan to test also different models, such as leasing, to support client acquisition. We also anticipate generating additional revenue from data, algorithms, and AI solutions.
